Blunted IgE-mediated activation of mast cells in mice lacking the Ca 2+-activated K+ channel KCa3.1

Journal of Immunology

Volumn 180, Issue 12, 2008, Pages 8040-8047

  Shumilina, Ekaterina ^a   Lam, Rebecca S ^a,b   Wölbing, Florian ^a   Matzner, Nicole ^a   Zemtsova, Irina M ^a   Sobiesiak, Malgorzata ^a   Mahmud, Hasan ^a   Sausbier, Ulrike ^a   Biedermann, Tilo ^a   Ruth, Peter ^a   Sausbier, Matthias ^a   Lang, Florian ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b MAX PLANCK INSTITUTE OF BIOPHYSICS   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA N ACETYLHEXOSAMINIDASE; CALCIUM ACTIVATED POTASSIUM CHANNEL; CALCIUM ACTIVATED POTASSIUM CHANNEL 3.1; CALCIUM ION; CD34 ANTIGEN; ENDOTHELIN 1; FC RECEPTOR; HISTAMINE; IMMUNOGLOBULIN E; STEM CELL FACTOR RECEPTOR; UNCLASSIFIED DRUG; ANTIGEN; CALCIUM; INTERMEDIATE CONDUCTANCE CALCIUM ACTIVATED POTASSIUM CHANNEL; KCNN4 PROTEIN, MOUSE; NITROBENZENE DERIVATIVE;

ANAPHYLAXIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; BODY TEMPERATURE; BONE MARROW CELL; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CELL ACTIVATION; CELL GROWTH; CELL MEMBRANE POTENTIAL; CELL VOLUME; CONTROLLED STUDY; GENOTYPE; HISTAMINE RELEASE; HYPERPOLARIZATION; MAST CELL; MAST CELL DEGRANULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; WILD TYPE; ACTIVE TRANSPORT; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SIZE; DEGRANULATION; DRUG ANTAGONISM; FEMALE; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; MALE; METABOLISM; MOUSE MUTANT; PATHOLOGY; PHYSIOLOGY;

ANAPHYLAXIS; ANIMALS; ANTIGENS; BIOLOGICAL TRANSPORT, ACTIVE; BONE MARROW CELLS; CALCIUM; CELL DEGRANULATION; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SIZE; CELLS, CULTURED; DINITROBENZENES; ENDOTHELIN-1; FEMALE; GENE EXPRESSION REGULATION; IMMUNOGLOBULIN E; INTERMEDIATE-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNELS; MALE; MAST CELLS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT;

EID: 50949133393     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.180.12.8040     Document Type: Article

References (55)

1. Kawakami, T., and S. J. Galli. 2002. Regulation of mast-cell and basophil function and survival by IgE. Nat. Rev. Immunol. 2: 773-786.
2. Kawakami, T., and J. Kitaura. 2005. Mast cell survival and activation by IgE in the absence of antigen: a consideration of the biologic mechanisms and relevance. J. Immunol. 175: 4167-4173.
3. Pawankar, R. 2005. Mast cells in allergic airway disease and chronic rhinosinus-itis. Chem. Immunol. Allergy 87: 111-129.
4. Bradding, P. 2003. The role of the mast cell in asthma: a reassessment. Curr. Opin. Allergy Clin. Immunol. 3: 45-50.
5. Biedermann, T, M. Kncilling, R. Mailhammer, K. Maicr, C. A. Sander, G. Kollias, S. L. Kunkel, L. Hultner, and M. Rocken. 2000. Mast cells control neutrophil recruitment during T cell-mediated delayed-type hypersensilivity reactions through tumor necrosis factor and macrophage inflammatory protein 2. J. Exp. Med. 192: 1441-1452.
6. Secor, V. II., W. E. Secor, C. A. Gutekunst, and M. A. Brown. 2000. Mast cells arc essential for early onset and severe disease in a murine model of multiple sclerosis. J. Exp. Med. 191: 813-822.
7. Van Loveren, H., R. Meade, and P. W. Askenase. 1983. An early component of delayed-type hypcrsensitivity mediated by T cells and mast cells. J. Exp. Med. 157: 1604-1617.
8. Asada, H., J. Linton, and S. I. Katz. 1997. Cytokine gene expression during the elicitation phase of contact sensitivity: regulation by endogeious IL-4. J. Invest. Dermatol. 108:406-411.
9. Galli, S. J., and S. Nakae. 2003. Mast cells to the defense. Nat. Immunol. 4: 1160-1162.
10. Galli, S. J., J. Kalesnikoff, M. A. Grimbaldeston, A. M. Piliponsky, C. M. Williams, and M. Tsai. 2005. Mast cells as "tunable" effector and immu-noregulatory cells: recent advances. Annu. Rev. Immunol. 23: 749-786.
11. Hill, P. B., A. J. MacDonald, E. M. Thornton, G. F. Newlands, S. J. Galli, and H. R. Miller' 1996. Stem cell factor enhances immunoglobulin E-dependent mediator release from cultured rat bone marrow-derived mast cells: activation of previously unresponsive cells demonstrated by a novel ELISPOT assay. Immunology 87: 326-333.
12. Nakae, S., H. Suto, M. Kakurai, J. D. Sedgwick, M. Tsai, and S. J. Galli. 2005. Mast cells enhance T cell activation: Importance of mast cell-derived TNF. Proc. Nail. Acad. Sci. USA 102: 6467-6472.
13. Nakae, S., H. Suto, M. Iikura, M. Kakurai, J. D. Sedgwick, M. Tsai, and S. J. Galli. 2006. Mast cells enhance T cell activation: importance of mast cell costimulatory molecules and secreted TNF. J. Immunol. 176: 2238-2248.
14. Rivera, J., and A. M. Gilfillan. 2006. Molecular regulation of mast cell activation. J. Allergy Clin. Immunol. 117: 1214-1225.
15. Huang, C, A. Sali, and R. L. Stevens. 1998. Regulation and function of mast cell proteases in inflammation. J. Clin. Immunol. 18: 169-183.
16. Maurer, M., and M. Metz. 2005. The status quo and quo vadis of mast cells. Exp. Dermatol. 14: 923-929.
17. Stelekati, E., Z. Orinska, and S. Bulfone-Paus. 2007. Mast cells in allergy: innate instructors of adaptive responses. Imununobiology 212: 505-519.
18. Yamamura, H., T. Nabe, S. Kohno, and K. Ohata. 1994. Endothelin-1, one of the most potent histaminc releasers in mouse peritoneal mast cells. Eur. J. Pharmacol. 265: 9-15.
19. Yamamura, H., T. Nabe, S. Kohno, and K. Ohata. 1995. Mechanism of histamine release by endothelin-1 distinct from that by antigen in mouse bone marrow-derived mast cells. Eur. J. Pharmacol. 288: 269-275.
20. 2+ influx. Biochem. Pharmacol. 55: 1255-1262.
21. Guzman, R. E., P. Bolanos, A. Delgado, H. Rojas, R. DiPolo, C. Caputo, and E. H. Jaffe. 2007. Dcpolymerisation and rearrangement of actin filaments during exocytosis in rat peritoneal mast cells: involvement of ryanodine-sensitive calcium stores. PJfugers Arch. 454: 131-141.
22. Hermosura, M. C, H. Takeuchi, A. Fleig, A. M. Riley, B. V. Potter, M. Hirata, and R. Penner. 2000. InsP4 facilitates store-operated calcium influx by inhibition of InsP3 5-phosphatase. Nature 408: 735-740.
23. Jaffe, E. H., P. Bolanos, G. Galvis, and C. Caputo. 2004. Ryanodine receptors in peritoneal mast cells: possible role in the modulation of exocytotic activity. PJfugers Arch. 447: 377-386.
24. 2+ signals triggered by different phospholipid pathways in antigen stimulation of human mast cells. J. Biol. Chem 277: 17255-17262.
25. Stokes, A. J., L. M. Shimoda, J. W. Lee, C. Rillero, Y. T. Chang, and H. Turner. 2006. FCERI control of Ras via inositol (1,4,5) trisphosphate 3-kinase and inositol tetrakisph6sphate. Cell. Signal. 18: 640-651.
26. Bradding, P., Y. Okayama, N. Kambe, and H. Saito. 2003. Ion channel gene expression in human lung, skin, and cord blood-derived mast cells. J. Leukocyte Biol. 73: 614-620.
27. Buess, M., O. Engler, H. H. Hirsch, and C. Moroni. 1999. Search for oncogenic regulators in an autocrine tumor model using differential display PCR: identification of novel candidate genes including the calcium channel mtrp6. Oncogene 18: 1487-1494.
28. Demick, G., G. Alvarez de Toledo, and M. Lindau. 2003. Exocytosis of single chromaffin granules in cell-free inside-out membrane patches. Nat. Cell Biol. 5: 358-362.
29. Duffy, S. M., M. L. Leyland, E. C. Conley, and P. Bradding. 2001. Voltage-dependent and calcium-activated ion channels in the human mast cell line HMC-1. J. Leukocyte Biol. 70: 233-240.
30. Duffy, S. M., W. J. Lawley, E. C. Conley, and P. Bradding. 2001. Resting and activation-dependent ion channels in human mast cells. J. Immunol. 167: 4261-4270.
31. Kahr, H., R. Schindl, R. Fritsch, B. Heinze, M. Hofbauer, M. E. Hack, M. A. Mortelmaier, K. Groschner, J. B. Peng, H. Takanaga, et al. 2004. CaTl knock-down strategies fail to affect CRAC channels in mucosal-type mast cells. J. Physiol. 557: 121-132.
32. Mazurek, N., G. Berger, and I. Pccht. 1980. A binding site on mast cells and basophils for the anti-allergic drjg cromolyn. Nature 286: 722-723.
33. Stokes, A. J., L. M. Shimoda, M. Koblan-Huberson, C. N. Adra, and H. Turner. 2004. A TRPV2-PKA signaling module for transduction of physical stimuli in mast cells. J. Exp. Med. 200: 137-147.
34. Hoth, M., and R. Penner. 1992. Depletion of intracellular calcium stores activates a calcium current in mast cells. Nature 355: 353-356.
35. Vennekens, R., J. Olausson, M. Meissner, W. Bloch, I. Mathar, S. E. Philipp, F. Schmitz, P. Weissgerber, B. Nilius, V. Flockerzi, and M. Freichel. 2007. Increased IgE-dcpcndent mast cell activation and anaphylactic responses in mice lacking the calcium-activated nonselective cation channel TRPM4. Nat. Immunol. 8: 312-320.
36. Mohr, F. C, and C. Fewtrell. 1987. IgE receptor-mediated depolarization of rat basophilic leukemia cells measured with the fluorescent probe bis-oxonol. J. Immunol. 138: 1564-1570.
37. Labrecque, G. F., D. Holowka, and B. Baird. 1989. Antigen-triggered membrane potential changes in IgE-sensitized rat basophilic leukemia cells: evidence for a rcpolarizing response that is important in the stimulation of cellular degranula-tion. J. Immunol. 142: 236-243.
38. 2+ influx and dcgranulation in human lung mast cells. J. Allergy Clin: Immunol. 114: 66-72.
39. Narenjkar, J., el-S. K. Assem, and C. R. Ganellin. 2004. Inhibition of the antigen-induced activation of RBL-2H3 cells by cetiedil and some of its analogues. Eur. J. Pharmacol. 483: 107-116.
40. Narenjkar, J., S. J. Marsh, and cl-S. K. Asscm. 2004. Inhibition of the antigen-induced activation of RBL-2H3 cells by charybdotoxin and cetiedil. Eur. J. Pharmacol. 483: 95-106.
41. + channels are required for human lung mast cell migration. Thorax 61: 880-885.
42. Hill, K., S. McNulty, and A. D. Randall. 2004. Inhibition of TRPM2 channels by the antifungal agents clotrimazole and econazole. Naunyn Schmiedebergs Arch. Pharmacol. 370: 227-237.
43. Schilling, T., and C. Eder. 2007. TRAM-34 inhibits nonselective cation channels. Pflugers Arch. 454: 559-563.
44. + secretion occurs via BK channels. J. Am. Soc. Nephrol. 17: 1275-1282.
45. Hamill, O. P., A. Marty, E. Neher, B. Sakmann, and F. J. Sigworth. 1981. Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflugers Arch. 391: 85-100.
46. Barry, P. H., and J. W. Lynch. 1991. Liquid junction potentials and small cell effects in patch-clamp analysis. J. Membr. Biol. 121: 101-117.
47. 2+ entry by IGF-1 in human embryonic kidney cells. Pflugers Arch. 445: 74-79.
48. Kerrigan, M. J., C. S. Hook, A. Qusous, and A. C. Hall. 2006. Regulatory volume increase (RVI) by in situ and isolated bovine articular chondrocytes. J. Cell. Physiol. 209:481-492.
49. Lang, F., G. L. Busch, M. Ritter, H. Volkl, S. Waldegger, E. Gulbins, and D. Haussinger. 1998. Functional significance of cell volume regulatory mechanisms. Physiol. Rev. 78: 247-306.
50. Tkaczyk, C, M. A. Beaven, S. M. Brachman, D. D. Metcalfe, and A. M. Gilfillan. 2003. The phospholipase Cγl-dependent pathway of FcεRI-mediated mast cell activation is regulated independently of phosphatidylinositol 3-kinase. J. Biol. Chem. 278: 48474-48484.
51. 2+ influx through receptor-mediated activation of nonspecific cation channels in mast cells. Proc. Nail. Acad. Sci. USA 90: 3068-3072.
52. Matthews, G., E. Neher, and R. Penner. 1989. Second messenger-activated calcium influx in rat peritoneal mast cells. J. Physiol. 418: 105-130.
53. Matthews, G., E. Neher, and R. Penner. 1989. Chloride conductance activated by external agonists and internal messengers in rat peritoneal mast cells. J. Physiol. 418: 131-144.
54. + channel. Circ. Res. 99: 537-544.
55. 2+-activated potassium channel Kcnn4. J. Biol. Chem. 279: 47681-47687.